Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Moderna
MRNA
|
+$269M |
| 2 |
Amazon
AMZN
|
+$242M |
| 3 |
Apple
AAPL
|
+$215M |
| 4 |
Amgen
AMGN
|
+$212M |
| 5 |
Citizens Financial Group
CFG
|
+$193M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$210M |
| 2 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$195M |
| 3 |
iShares GSCI Commodity Dynamic Roll Strategy ETF
COMT
|
+$154M |
| 4 |
MXIM
Maxim Integrated Products
MXIM
|
+$127M |
| 5 |
WORK
Slack Technologies, Inc.
WORK
|
+$115M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.58% |
| 2 | Financials | 13.47% |
| 3 | Healthcare | 12.09% |
| 4 | Consumer Discretionary | 10.78% |
| 5 | Industrials | 8.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2501
Autohome
ATHM
$2.6B
| $3.79M | ﹤0.01% |
80,655
+1,690
| +2% | +$79.8K |
|
2502
JFrog
FROG
$11.5B
| $3.77M | ﹤0.01% |
112,649
+3,254
| +3% | +$131K |
|
2503
National CineMedia
NCMI
$252M
| $3.77M | ﹤0.01% |
105,968
-12,476
| -11% | -$405K |
|
|
LORL
2504
DELISTED
Loral Space and Communications, Inc.
LORL
| $3.76M | ﹤0.01% |
87,335
-79
| -0.1% | -$3.06K |
|
|
TRIL
2505
DELISTED
Trillium Therapeutics Inc.
TRIL
| $3.74M | ﹤0.01% |
213,112
+5,759
| +3% | +$67.3K |
|
|
LL
2506
DELISTED
LL Flooring Holdings, Inc.
LL
| $3.73M | ﹤0.01% |
199,847
+1,746
| +0.9% | +$34.5K |
|
|
GATO
2507
DELISTED
Gatos Silver, Inc.
GATO
| $3.73M | ﹤0.01% |
320,584
+141,135
| +79% | +$1.97M |
|
|
VVNT
2508
DELISTED
Vivint Smart Home, Inc. Class A Common Stock
VVNT
| $3.73M | ﹤0.01% |
394,099
-46,096
| -10% | -$551K |
|
2509
Stoke Therapeutics
STOK
$2.02B
| $3.71M | ﹤0.01% |
145,997
+9,375
| +7% | +$261K |
|
2510
OptimizeRx
OPRX
$165M
| $3.71M | ﹤0.01% |
43,357
+3,010
| +7% | +$189K |
|
2511
Arrow Financial
AROW
$723M
| $3.71M | ﹤0.01% |
114,439
+987
| +0.9% | +$32.4K |
|
2512
Inseego
INSG
$77.7M
| $3.7M | ﹤0.01% |
55,561
+6,008
| +12% | +$502K |
|
|
AKRO
2513
DELISTED
Akero Therapeutics
AKRO
| $3.7M | ﹤0.01% |
165,353
+26,360
| +19% | +$597K |
|
2514
Midland States Bancorp
MSBI
$698M
| $3.69M | ﹤0.01% |
149,354
+5,781
| +4% | +$144K |
|
2515
Precigen
PGEN
$2.32B
| $3.69M | ﹤0.01% |
738,344
+12,414
| +2% | +$71.5K |
|
|
PTVE
2516
DELISTED
Pactiv Evergreen Inc. Common stock
PTVE
| $3.68M | ﹤0.01% |
294,110
+6,244
| +2% | +$84.7K |
|
2517
AnaptysBio
ANAB
$1.66B
| $3.68M | ﹤0.01% |
135,638
-7,189
| -5% | -$182K |
|
|
IGMS
2518
DELISTED
IGM Biosciences
IGMS
| $3.67M | ﹤0.01% |
55,867
+4,986
| +10% | +$381K |
|
2519
Outdoor Holding Co
POWW
$255M
| $3.65M | ﹤0.01% |
593,865
+80,401
| +16% | +$579K |
|
|
SWI
2520
DELISTED
SolarWinds Corporation Common Stock
SWI
| $3.65M | ﹤0.01% |
218,319
-295,789
| -58% | -$5.47M |
|
2521
DXP Enterprises
DXPE
$3B
| $3.65M | ﹤0.01% |
123,447
+2,797
| +2% | +$85.8K |
|
|
FLIC
2522
DELISTED
First of Long Island Corp
FLIC
| $3.63M | ﹤0.01% |
176,327
+957
| +0.5% | +$20.1K |
|
2523
Tootsie Roll Industries
TR
$3.02B
| $3.62M | ﹤0.01% |
137,923
+2,085
| +2% | +$58.8K |
|
|
QUOT
2524
DELISTED
Quotient Technology Inc
QUOT
| $3.61M | ﹤0.01% |
619,633
+52,743
| +9% | +$442K |
|
|
ONT
2525
Onterris Inc
ONT
$615M
| $3.6M | ﹤0.01% |
58,379
+5,677
| +11% | +$297K |
|
Similar funds
Charles Schwab's Q3 2021 Portfolio in Review
As of Q3 2021, Charles Schwab held 3,610 positions worth $306B, up 1.6% from $301B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Charles Schwab's Q3 2021 filing shows 202 new, 2,185 increased, 922 reduced and 109 closed positions. Its largest new stake was iShares Core 1-5 Year USD Bond ETF: 3,548,215 shares worth $181M. The largest sale was Vanguard FTSE Emerging Markets ETF, an estimated $210M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q3 2021 buy was iShares Core 1-5 Year USD Bond ETF: 3,548,215 shares worth $181M.
- Charles Schwab added most to Moderna in Q3 2021, an estimated $269M increase.
- Charles Schwab's biggest Q3 2021 reduction was Vanguard FTSE Emerging Markets ETF, cutting an estimated $210M.
- Charles Schwab fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $195M.
- Charles Schwab's ten largest holdings make up 17% of its $306B portfolio in Q3 2021.
- Charles Schwab opened 202 new positions and closed 109 in Q3 2021.
- Charles Schwab's portfolio value rose 1.6% quarter-over-quarter to $306B.
Based on Charles Schwab's 13F filing for Q3 2021, filed 16 Nov 2021.